» Articles » PMID: 28657777

Epithelial Deletion of Sulf2 Exacerbates Bleomycin-Induced Lung Injury, Inflammation, and Mortality

Overview
Date 2017 Jun 29
PMID 28657777
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Epithelial injury has been proposed to be the initiating factor in the pathogenesis of idiopathic pulmonary fibrosis (IPF). We have shown previously that heparan sulfate 6-O-endosulfatase (Sulf) 2 is overexpressed in the hyperplastic type II alveolar epithelial cells (AECs) in the IPF lungs. By removing 6-O-sulfates from specific heparan sulfate intrachain sites, Sulf2 modulates the functions of many growth factors and cytokines. In this study, we hypothesized that Sulf2 plays a regulatory role in alveolar epithelial injury and repair, using the murine bleomycin model. Consistent with our findings in human IPF lungs, bleomycin treatment in mice resulted in up-regulation of Sulf2 mRNA in whole-lung extracts and overexpression of Sulf2 protein in type II AECs on lung tissue sections. Sulf2 protein was detectable in bronchoalveolar lavage fluid at baseline, and its level was significantly increased after bleomycin exposure. To study the role of Sulf2 in alveolar injury and repair in vivo, we generated a doxycycline-inducible epithelial-specific Sulf2 conditional knockout (Sulf2 CKO) mouse line. After bleomycin exposure, Sulf2 CKO mice exhibited enhanced neutrophil infiltration in the lung, with elevated levels of total protein, lactate dehydrogenase, and cytokines (granulocyte colony-stimulating factor and interferon-γ-inducible protein 10) in bronchoalveolar lavage fluid compared with wild-type littermates. We further showed that both the p53-p21 DNA damage response and the transforming growth factor-β1 signaling pathway were up-regulated in Sulf2 CKO mice compared with wild-type. Finally, Sulf2 CKO mice suffered increased mortality after bleomycin exposure. In conclusion, Sulf2 expression in type II AECs plays a protective role in epithelial injury, inflammation and mortality.

Citing Articles

Editor's Choice Development of a method to measure the activity of heparan sulfate 6-endosulfatase for biological research.

Wang Z, Benicky J, Mukherjee P, Laing J, Xu Y, Pagadala V Glycobiology. 2025; 35(4).

PMID: 40044126 PMC: 11892103. DOI: 10.1093/glycob/cwaf012.


Myeloid deficiency of heparan sulfate 6-O-endosulfatases impairs bone marrow hematopoiesis.

Whitehead A, Wang Z, Boustany R, Vives R, Lazartigues E, Liu J Matrix Biol. 2024; 134:107-118.

PMID: 39368561 PMC: 11585435. DOI: 10.1016/j.matbio.2024.10.002.


The extracellular heparan sulfatase SULF2 limits myeloid IFNβ signaling and Th17 responses in inflammatory arthritis.

Swart M, Redpath A, Ogbechi J, Cardenas R, Topping L, Compeer E Cell Mol Life Sci. 2024; 81(1):350.

PMID: 39141086 PMC: 11335274. DOI: 10.1007/s00018-024-05333-w.


Effects of reprogrammed splenic CD8 T-cells in vitro and in mice with spontaneous metastatic Lewis lung carcinoma.

Skurikhin E, Ermakova N, Zhukova M, Pan E, Widera D, Sandrikina L BMC Cancer. 2024; 24(1):522.

PMID: 38664641 PMC: 11046928. DOI: 10.1186/s12885-024-12203-y.


A genomic perspective of the aging human and mouse lung with a focus on immune response and cellular senescence.

He M, Borlak J Immun Ageing. 2023; 20(1):58.

PMID: 37932771 PMC: 10626779. DOI: 10.1186/s12979-023-00373-5.


References
1.
Sikora A, Hellec C, Carpentier M, Martinez P, Delos M, Denys A . Tumour-necrosis factor-α induces heparan sulfate 6-O-endosulfatase 1 (Sulf-1) expression in fibroblasts. Int J Biochem Cell Biol. 2016; 80:57-65. DOI: 10.1016/j.biocel.2016.09.021. View

2.
Langsdorf A, Do A, Kusche-Gullberg M, Emerson Jr C, Ai X . Sulfs are regulators of growth factor signaling for satellite cell differentiation and muscle regeneration. Dev Biol. 2007; 311(2):464-77. DOI: 10.1016/j.ydbio.2007.08.053. View

3.
Okudela K, Ito T, Mitsui H, Hayashi H, Udaka N, KANISAWA M . The role of p53 in bleomycin-induced DNA damage in the lung. A comparative study with the small intestine. Am J Pathol. 1999; 155(4):1341-51. PMC: 1867000. DOI: 10.1016/S0002-9440(10)65236-4. View

4.
Inoshima I, Kuwano K, Hamada N, Yoshimi M, Maeyama T, Hagimoto N . Induction of CDK inhibitor p21 gene as a new therapeutic strategy against pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2004; 286(4):L727-33. DOI: 10.1152/ajplung.00209.2003. View

5.
Lum D, Tan J, Rosen S, Werb Z . Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2. Mol Cell Biol. 2006; 27(2):678-88. PMC: 1800820. DOI: 10.1128/MCB.01279-06. View